Teva Pharmaceutical Indus... (TEVA)
NYSE: TEVA
· Real-Time Price · USD
17.63
0.09 (0.51%)
At close: Aug 15, 2025, 9:59 AM
Teva Pharmaceutical Industries Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 16.63B | 16.61B | 16.55B | 16.78B | 16.3B | 16.02B | 15.85B | 15.27B | 15.02B | 14.93B | 14.93B | 15.14B | 15.43B | 15.56B | 15.88B | 16.23B | 16.32B | 16.28B |
Cost of Revenue | 8.38B | 8.45B | 8.48B | 8.41B | 8.23B | 8.17B | 8.2B | 8.27B | 8.2B | 8.11B | 7.95B | 7.89B | 8.05B | 8.1B | 8.28B | 8.64B | 8.67B | 8.74B |
Gross Profit | 8.25B | 8.17B | 8.07B | 8.37B | 8.07B | 7.85B | 7.64B | 7B | 6.82B | 6.82B | 6.97B | 7.25B | 7.38B | 7.46B | 7.59B | 7.59B | 7.65B | 7.54B |
Operating Income | 894M | 1.25B | 1.39B | 2.14B | 2.55B | 1.09B | 418M | 439M | 756M | 453M | -247M | -912M | -961M | 570M | 1.72B | 2.04B | -2.92B | -3.33B |
Interest Income | n/a | n/a | n/a | n/a | n/a | 226M | 226M | 453M | 453M | 227M | 227M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -74M | -523M | -1.28B | -564M | -165M | -833M | -638M | -2.21B | -2.12B | -2.37B | -3.06B | -2.14B | -1.92B | -456M | 659M | 971M | -3.87B | -4.23B |
Net Income | -158M | -1.28B | -1.64B | -992M | -475M | -493M | -574M | -2.22B | -2.25B | -1.62B | -2.35B | -1.29B | -1.05B | -615M | 417M | 726M | -3.92B | -3.98B |
Selling & General & Admin | 3.75B | 3.73B | 3.7B | 3.65B | 3.57B | 3.54B | 3.5B | 3.43B | 3.41B | 3.41B | 3.45B | 3.52B | 3.58B | 3.53B | 3.53B | 3.63B | 3.63B | 3.63B |
Research & Development | 979M | 1B | 999M | 978M | 991M | 962M | 954M | 937M | 859M | 847M | 838M | 872M | 919M | 939M | 968M | 1.02B | 1.05B | 1.03B |
Other Expenses | 1.14B | 1.14B | 950M | 1M | 10M | 9M | 529M | 529M | 521M | 521M | 1.35B | 1.35B | 1.35B | 1.35B | 5M | 5M | -2M | -2M |
Operating Expenses | 5.87B | 5.88B | 5.65B | 4.63B | 4.56B | 4.5B | 4.97B | 4.89B | 4.79B | 4.78B | 5.63B | 5.74B | 5.85B | 5.82B | 4.5B | 4.65B | 4.68B | 4.66B |
Interest Expense | 736M | 977M | 1B | 1.02B | 1.03B | 1.06B | 1.07B | 1.05B | 1.02B | 968M | 966M | 901M | 890M | 919M | 951M | 1.17B | 1.04B | 1.03B |
Selling & Marketing Expenses | 2.55B | 2.55B | 2.54B | 2.5B | 2.45B | 2.4B | 2.33B | 2.27B | 2.24B | 2.23B | 2.27B | 2.35B | 2.41B | 2.43B | 2.43B | 2.48B | 2.49B | 2.47B |
Cost & Expenses | 14.26B | 14.33B | 14.13B | 13.04B | 12.79B | 12.67B | 13.17B | 13.16B | 12.99B | 12.89B | 13.59B | 13.63B | 13.9B | 13.92B | 12.78B | 13.29B | 13.35B | 13.4B |
Income Tax Expense | 92M | 801M | 675M | 688M | 607M | -39M | -6M | 107M | 226M | -658M | -637M | -815M | -846M | 152M | 212M | 215M | 155M | -47M |
Shares Outstanding (Basic) | 1.15B | 1.14B | 1.13B | 1.13B | 1.13B | 1.12B | 1.12B | 1.12B | 1.12B | 1.11B | 1.11B | 1.11B | 1.11B | 1.11B | 1.1B | 1.1B | 1.1B | 1.1B |
Shares Outstanding (Diluted) | 1.16B | 1.16B | 1.13B | 1.13B | 1.13B | 1.12B | 1.14B | 1.14B | 1.12B | 1.11B | 1.11B | 1.12B | 1.11B | 1.11B | 1.1B | 1.11B | 1.11B | 1.11B |
EPS (Basic) | -0.14 | -1.14 | -1.45 | -0.85 | -0.39 | -0.41 | -0.49 | -2 | -2.02 | -1.46 | -2.12 | -1.16 | -0.95 | -0.55 | 0.38 | 0.66 | -3.57 | -3.63 |
EPS (Diluted) | -0.16 | -1.15 | -1.45 | -0.85 | -0.39 | -0.41 | -0.49 | -2 | -2.02 | -1.46 | -2.12 | -1.16 | -0.95 | -0.55 | 0.38 | 0.66 | -3.57 | -3.63 |
EBITDA | 1.69B | 1.49B | 770M | 2.02B | 2.86B | 2.22B | 2.47B | 466M | 416M | 206M | -476M | 1.17B | 1.21B | 2.39B | 3.59B | 3.55B | -1.49B | -1B |
EBIT | 459M | 454M | -292M | 410M | 806M | 156M | 371M | -1.22B | -1.14B | -1.44B | -2.14B | -1.33B | -1.13B | 430M | 1.58B | 2.2B | -2.76B | -3.2B |
Depreciation & Amortization | 772M | 1.03B | 1.06B | 1.06B | 1.08B | 1.12B | 1.15B | 1.19B | 1.23B | 1.29B | 1.31B | 1.32B | 1.33B | 1.28B | 1.33B | 1.41B | 1.46B | 1.53B |